Ryman Healthcare Stock Rallies Nearly 8% Amid Strong Sales, Rising Free Cash Flow And Investor Buying
Shares of Ryman Healthcare climbed 7.94%, or $0.135, to $1.835 as the New Zealand and Australian retirement village and aged care operator continued to benefit from a broader turnaround story that has gained momentum with investors over recent months, supported by improving sales figures, rising free cash flow and notable institutional buying activity.
Ryman, founded in Christchurch in 1984, is New Zealand's largest retirement living and aged care provider and a leading integrated operator in the state of Victoria, Australia. The company owns and operates 47 integrated retirement villages across both countries, offering a range of accommodation options spanning independent living apartments and townhouses through to assisted living, rest home care, hospital-level care and dementia care.
A resilient first-quarter trading update
Much of the recent positive sentiment surrounding Ryman's stock has been tied to the company's first-quarter trading update for the period ending June 30, 2026, released July 14. Ryman reported 325 sales of retirement living occupation right agreements during the quarter, comprising 265 resales and 60 new sales, with net resale contract volumes up 7% compared with the same period the previous year, driven by strong demand for the company's serviced apartment offerings.
Ryman chief executive Naomi James highlighted the resilience of the company's resale market despite broader external pressures affecting housing conditions. "Resales have held up despite the external impacts of global events on housing market conditions," James said. "Serviced apartments remain a standout, supported by our targeted sales strategies and growing demand for........
